STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial
NA
This is a multicenter, open-label, randomized controlled study meant to com...
Status
Unknown
Location
Fuwai Hospital, National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences
Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)
NA
The management of patients with unprotected left main coronary artery (LMCA...
Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk
NA
Patients with acute coronary syndrome (ACS) who have both high ischemic ris...